Poland
· Delayed Price · Currency is PLN Genomed Spólka Akcyjna Company Description
Genomed Spólka Akcyjna provides DNA analysis and congenital diseases diagnostic services in Poland.
It develops molecular diagnostics based on DNA sequencing for the application of prophylactics and treatment, such as replacement or gene therapy.
The company also offers the analysis of mutations responsible for congenital diseases in approximately 6,500 genes; and next-generation sequencing technology.
In addition, it provides various types of DNA sequence analysis, including polymorphism analysis, and the sequencing of phage genetic material, or bacteria and yeast genomes; and next-generation sequencing and genetic counseling services.
Further, the company offers DNA oligonucleotides synthesis, RNA oligonucleotides and peptide synthesis, various nucleotide modifications, and the 4LAB automated pipetting workstation, as well as laboratory equipment through the e-shop.
It serves scientific institutes, universities, hospitals, and biotechnological and pharmaceutical companies, as well as healthcare networks and individual customers.
Genomed Spólka Akcyjna was founded in 2007 and is based in Warsaw, Poland.
| Country | Poland |
| Founded | 2007 |
| Industry | In Vitro and In Vivo Diagnostic Substances |
| Employees | 44 |
| CEO | Anna Boguszewska-Chachulska |
Contact Details
Address: ul. Ponczowa 12 Warsaw, 02-971 Poland | |
| Phone | 48 22 644 6019 |
| Website | genomed.pl |
Stock Details
| Ticker Symbol | GEN |
| Exchange | Warsaw Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | PLN |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Anna Boguszewska-Chachulska | Chief Executive Officer |